Hospital Doctor

IVOS CQUIN: What's new for 2024-25?

23 April 2024 12:30pm – 1:30pmBST (+01:00)
Virtual (MS Teams (link to follow))

About the event

This session from the Antimicrobial Prescribing & Medicines Optimisation workstream of NHS England’s AMR Programme and the UK Health Security Agency will provide an overview of the evidence base supporting IV to oral antibiotic switch, summarise the performance for the 2023/24 CQUIN, share examples of improvement in IVOS rates from secondary care organisations, explain the changes to the CQUIN for 2024/25 and explain how the paediatric IV to oral switch criteria were developed and validated.

Why it’s important

Timely appropriate IV to oral antibiotic switch (IVOS)  improves patient care, reduces length of stay, reduces nursing workload, reduces costs and reduces the carbon footprint associated with IV medications. Data from the 2023/24 IVOS CQUIN shows that many trusts made improvements to the rate of IVOS for adult patients, yet there is still considerable room for further improvement. IVOS criteria for children have now been developed and validated and provide an opportunity to drive improvement in the management of infection in children in secondary care. This session will equip teams with insight, support, and shared learning to continue to address the widespread use of IV antibiotics in secondary care in adult and paediatric populations, and outline the requirements for the 2024/25 CQUIN.

What will be covered/what you’ll learn

  • Learn about progress to date with the 2023/24 IVOS CQUIN
  • Hear about how two secondary care organisations delivered improvement in IVOS
  • Learn about the new evidence bundle for IVOS
  • Hear why IV to oral switch is important for paediatric patients
  • Learn about the recently developed paediatric IV to oral switch criteria
  • Hear about the 2024/25 CQUIN for IVOS and what’s required to achieve it


Registration is available to all NHS staff.  Please register using your NHS email address.

Questions about this event?

Name: The APMO Team

Telephone:---not applicable --

General FAQs